What is NDC 51662-1544?

51662-1544 is the product NDC for Naloxone Hydrochloride, Naloxone hydrochloride .4 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naloxone Hydrochloride?

77 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naloxone Hydrochloride NDC 51662-1544 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1544Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1544Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1544-1	51662154401	1 mL in 1 VIAL, SINGLE-DOSE (51662-1544-1)Marketed from Aug 8, 2021
51662-1544-3	51662154403	10 POUCH in 1 CASE (51662-1544-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1544-2) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Apr 22, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naloxone Hydrochloride
Generic name (nonproprietary): naloxone hydrochloride
Active ingredients: Naloxone hydrochloride — .4 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous, Subcutaneous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212455
Marketing start: Aug 8, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 51662-1544_10352ea7-15c5-5c6c-e063-6394a90ae130SPL ID 10352ea7-15c5-5c6c-e063-6394a90ae130SPL set ID c90e2d85-ed94-2c00-e053-2a95a90ad2a0RxCUI 1659929UNII F850569PQRUPC 0355150327010
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662154401 followed by a unit qualifier and the quantity

Package 51662-1544-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids, including propoxyphene, methadone and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine. Naloxone hydrochloride injection is also indicated for diagnosis of suspected or known acute opioid overdosage. Naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock (see CLINICAL PHARMACOLOGY; ADJUNCTIVE USE IN SEPTIC SHOCK ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1544

What is NDC 51662-1544?: 51662-1544 is the product NDC for Naloxone Hydrochloride, Naloxone hydrochloride .4 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naloxone Hydrochloride.
What is the active ingredient?: Naloxone hydrochloride.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naloxone Hydrochloride?: 77 other product NDCs are listed under this name. See all Naloxone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Naloxone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
naloxone hydrochloride	Naloxone hydrochloride .4 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Lifestar Pharma LLC	70756-850	70756-0850-1070756-0850-2570756-0850-82
Naloxone Hydrochloride	Naloxone hydrochloride .4 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Henry Schein, Inc.	0404-9773	00404-9773-01
Naloxone Hydrochloride	Naloxone hydrochloride .4 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0641-6193	00641-6193-10
naloxone hydrochloride	Naloxone hydrochloride 1 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Baxter Healthcare Corporation	43066-142	43066-0142-10
Naloxone Hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	BluePoint Laboratories	68001-645	68001-0645-45
Naloxone Hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Strategic Sourcing Services LLC	70677-1283	70677-1283-01
Naloxone Hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	AMERISOURCE BERGEN	46122-812	46122-0812-71
Naloxone Hydrochloride	Naloxone hydrochloride 4 mg/.1mL	Spray, MeteredNasal	Actavis Pharma, Inc.	0591-3871	00591-3871-99
Naloxone Hydrochloride	Naloxone hydrochloride 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Par Health USA, LLC	42023-224	42023-0224-01
Naloxone Hydrochloride	Naloxone hydrochloride 4 mg/.1mL	Spray, MeteredNasal	Teva Pharmaceuticals, Inc.	0480-3478	00480-3478-68

All 78 Naloxone Hydrochloride NDCs

Other NDCs under ANDA 212455

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212455
Product	Strength	Form · route	Labeler	Product NDC
Naloxone Hydrochloride	Naloxone hydrochloride .4 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Eugia US LLC	55150-327
Naloxone Hydrochloride	Naloxone hydrochloride .4 mg/mL	Injection, SolutionIntramuscular, Intravenous, Subcutaneous	Medical Purchasing Solutions, LLC	71872-7219